Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge

Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Portea Medical Expands Cancer Care Services Across India

New Delhi, August 6, 2025 — Portea Medical, India’s leading home healthcare provider, has announced the nationwide expansion of its comprehensive cancer care services. The initiative aims to ease access…

Health Ministry Seeks New SOPs for Plasma Fractionation Centres

New Delhi, August 6, 2025 — In a bid to overhaul the regulatory framework for plasma-derived medicines, the Union Health Ministry has proposed new guidelines for establishing and operating Plasma…

You Can Get Lung Cancer in Delhi Without Smoking, Warns New Study

Anuj Batra New Delhi, August 4 2025 — A groundbreaking study featured in the Asia Pacific Lung Cancer Policy Consensus (APAC Consensus) has raised alarm: air pollution in Delhi is…

CDSCO Launches 1-Year NOC System for Non-Medicinal Drug Imports

The Central Drugs Standard Control Organization (CDSCO) has announced the launch of a new online Dual Use No Objection Certificate (NOC) system through its SUGAM Portal, effective August 31, 2025.…

India Marks 15th Organ Donation Day as NOTTO Honours Leaders in Transplant Advocacy

The Union Health Ministry and the National Organ & Tissue Transplant Organisation (NOTTO) marked the 15th Indian Organ Donation Day with recognition for states, hospitals, and medical professionals leading transplant…

Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks

Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…

India’s Dengue Vaccine Trial Reaches 70%

India’s first dengue vaccine, DengiAll, reaches 70% enrolment in Phase III trials. It could protect against all four dengue virus strains. In many Indian cities, the hum of fogging machines…